[go: up one dir, main page]

AU1598399A - Injectable antifungal formulations - Google Patents

Injectable antifungal formulations

Info

Publication number
AU1598399A
AU1598399A AU15983/99A AU1598399A AU1598399A AU 1598399 A AU1598399 A AU 1598399A AU 15983/99 A AU15983/99 A AU 15983/99A AU 1598399 A AU1598399 A AU 1598399A AU 1598399 A AU1598399 A AU 1598399A
Authority
AU
Australia
Prior art keywords
antifungal formulations
injectable
injectable antifungal
formulations
antifungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15983/99A
Inventor
Vijay H. Naringrekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU1598399A publication Critical patent/AU1598399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU15983/99A 1997-12-01 1998-11-30 Injectable antifungal formulations Abandoned AU1598399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98095097A 1997-12-01 1997-12-01
US08980950 1997-12-01
PCT/US1998/024938 WO1999027932A1 (en) 1997-12-01 1998-11-30 Injectable antifungal formulations

Publications (1)

Publication Number Publication Date
AU1598399A true AU1598399A (en) 1999-06-16

Family

ID=25527989

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15983/99A Abandoned AU1598399A (en) 1997-12-01 1998-11-30 Injectable antifungal formulations

Country Status (2)

Country Link
AU (1) AU1598399A (en)
WO (1) WO1999027932A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020300A1 (en) 2000-08-22 2002-05-10 Pharmacia Corp COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
DK2814849T3 (en) 2012-02-15 2020-03-09 Cydex Pharmaceuticals Inc Process for Preparation of Cyclodextrin Derivatives
CN104704007A (en) 2012-02-28 2015-06-10 锡德克斯药物公司 Alkylated cyclodextrin compositions and methods of making and using same
SG11201503089WA (en) 2012-10-22 2015-05-28 Cydex Pharmaceuticals Inc Alkylated cyclodextrin compositions and processes for preparing and using the same
FI3183295T3 (en) 2014-08-22 2023-09-25 Cydex Pharmaceuticals Inc Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals

Also Published As

Publication number Publication date
WO1999027932A1 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
AU5636498A (en) Pesticide composition
AU2956297A (en) Antifungal compositions with improved bioavailability
AU5972598A (en) Pesticide compositions
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU9663498A (en) Sunscreen composition
AU6827898A (en) Detergent-package combination
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU3687297A (en) Insecticidal composition
AU1665999A (en) Pesticidal composition
AU5575398A (en) Hairdye compositions
AU1961799A (en) Pesticidal composition
AU8626598A (en) Pesticidal compositions
AU5844498A (en) Antifungal composition
AU8121998A (en) Composition
AU6525998A (en) Improved metallo-endopeptidases
AU1098499A (en) Emulsifier-lipid composition
AU6040398A (en) Fungicidal compositions
AU1873299A (en) Deodorant composition
AU1598399A (en) Injectable antifungal formulations
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU1494099A (en) Pesticidal compositions
AUPP053197A0 (en) Compositions
AU6984998A (en) Implement
AU6128398A (en) New composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase